COVID19, the novel “Coronavirus Disease 2019”, has proven the value proposition “open science” and Open Therapeutics’ free scientific collaborative platform, Therapoid.
Lives are being saved due to the implementation of open science.
Multiple outlets around the world are covering how open science is rapidly making discoveries around COVID19. (1)(2)(3)
Even the U.S. Administration is now supporting and promoting open science. (4)
The private sector simply can’t do this.
The private sector does not constitute a global think-tank because their cultures and organizations are built around closed science. Also, they don’t have the labor force.
Similar to Linux and the open source movement, the private sector companies do not have the labor force, infrastructure, or intellectual property structures to quickly muster resources to collaborate.
Open Therapeutics’ https://Therapoid.net, which is in beta, is positioned to help scientists around the world to freely and openly collaborate on solving the COVID19 crisis.
Therapoid will do this by providing an end-to-end scientific ecosystem that has free tools, services, access to up to $4T worth of unused intellectual properties (IP), and soon will reward scientific collaborations with AnthroTokens cryptocurrency.
One can think of Open Therapeutics as a “Github® for scientists” that rewards collaboration with a blockchain-based cryptocurrency.
The age of open science is upon us and Open Therapeutics is at the edge of delivering life saving opportunities.
(4) President Trump’s Science Advisor and Government Science Leaders from Around the World call on Publishers to make all COVID-19-Related Research Publically Available. https://twitter.com/whostp/status/1238501576123265025?s=21